Join us as we bring IP professionals together to learn and connect. More information coming soon! The 2025 Annual meeting will take place at the Westin Washington, DC, Downtown. Leadership Meetings on Wednesday, October 29. Programming scheduled October 30 - November 1.

We’re excited to welcome you to the 2026 AIPLA Spring Meeting, where innovation, technology, and intellectual property come together to shape the future. San Francisco is ready for your ideas, energy, and passion for IP!

Join us as we bring IP professionals together to learn and connect. More information coming soon! The 2026 Annual meeting will take place at the Westin Washington, DC, Downtown. Leadership Meetings on Wednesday, October 28. Programming scheduled October 29 - 31.

Expand your expertise in USPTO processes for obtaining retroactive foreign filing licenses in the U.S. Also, learn about strategies to navigate the complex international laws surrounding foreign filing licenses and how to avoid needing a retroactive license. Discover how to effectively manage foreign filing licenses and learn from real-world examples of approaches that ensure compliance across jurisdictions. We will also walk through approaches to obtaining retroactive foreign filing licenses and navigating the numerous requirements of the USPTO.

Arlington, VA. July 21, 2025 – The American Intellectual Property Law Association (AIPLA) submitted comments to the UPC Mediation and Arbitration Centre (PMAC) regarding its proposed Mediation Rules.

Arlington, VA. June 11, 2025 –The American Intellectual Property Law Association (AIPLA) submitted a letter in response to the nomination of John A. Squires as Director of the United States Patent & Trademark Office (“USPTO”). In view of his impressive background, AIPLA believes Mr. Squires is fully capable of undertaking this important role and appreciates the Senate Judiciary Committee giving this nominee prompt consideration.

Arlington, VA. May 17, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments in response to the National Medical Products Administration’s (NMPA) draft measures on the protection of drug trial data in China.

On February 26, 2025, the Supreme Court issued a unanimous decision in Dewberry Group, Inc. v. Dewberry Engineers Inc. The opinion is in line with the amicus brief filed by AIPLA on September 6, 2024.

On November 20, 2024, the USPTO published its final rule, “Setting and Adjusting Patent Fees During Fiscal Year 2025,” which will take effect on Sunday, January 19, 2025. Since the April 3, 2024, Notice of Proposed Rulemaking to establish or increase certain patent fees, AIPLA has actively engaged with its members by gathering feedback, submitting written comments, meeting with USPTO officials, and hosting informational webinars to keep members informed of the changes. As the implementation date approaches, members have raised additional questions, prompting AIPLA to seek clarification from the USPTO. Read below the results of our outreach with the Office.

On June 13, 2024, the Supreme Court decided that the Lanham Act’s names clause does not violate the First Amendment. The decision contrasts with the amicus brief filed by AIPLA on August 1, 2023.